We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

19 hedge funds and large institutions have $3.31M invested in Bio-Path Holdings Inc in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more capital invested

Capital invested by funds: $1.19M → $3.31M (+$2.12M)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

6% more funds holding

Funds holding: 18 → 19 (+1)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$426K
2
Morgan Stanley
Morgan Stanley
New York
+$225K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$163K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$133K
5
Citadel Advisors
Citadel Advisors
Florida
+$122K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$116K
2
Goldman Sachs
Goldman Sachs
New York
-$59K
3
WJA
Willis Johnson & Associates
Texas
-$40K
4
Renaissance Technologies
Renaissance Technologies
New York
-$22.4K
5
TRCT
Tower Research Capital (TRC)
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$872K +$163K +1,376 +28%
Renaissance Technologies
2
Renaissance Technologies
New York
$518K -$22.4K -189 -5%
SM
3
Sabby Management
Florida
$505K +$426K +3,596 New
BlackRock
4
BlackRock
New York
$421K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$397K +$133K +1,121 +66%
Morgan Stanley
6
Morgan Stanley
New York
$281K +$225K +1,902 +1,981%
Citadel Advisors
7
Citadel Advisors
Florida
$145K +$122K +1,030 New
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$124K +$105K +886 New
Bank of America
9
Bank of America
North Carolina
$17K – – –
HI
10
Human Investing
Oregon
$14K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$12K +$9.84K +83 +8,300%
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
$2K +$1.54K +13 New
IF
13
Ironwood Financial
Arizona
$1K +$474 +4 New
VF
14
Virtu Financial
New York
– -$116K -1,662 Closed
Goldman Sachs
15
Goldman Sachs
New York
– -$59K -840 Closed
WJA
16
Willis Johnson & Associates
Texas
– -$40K -569 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$6K -84 Closed
UBS Group
18
UBS Group
Switzerland
– -$3.44K -29 -91%

BPTH Hedge Fund Activity: Q1 2021 in Review

19 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2021, worth a combined $3.31M — up 179% from $1.19M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BPTH positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $426K. The largest seller was Virtu Financial, exiting entirely with an estimated $116K sold.

  • 19 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2021, up from 18 in Q4 2020.
  • Funds reported $3.31M of Bio-Path Holdings Inc stock for Q1 2021, up 179% quarter-over-quarter.
  • 5 funds opened new Bio-Path Holdings Inc positions in Q1 2021 and 4 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q1 2021 was Sabby Management, an estimated $426K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2021 was Virtu Financial, an estimated $116K sold.

Based on aggregated 13F filings for Q1 2021.